QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:MXL

MaxLinear (MXL) Stock Price, News & Analysis

$19.65
-0.62 (-3.06%)
(As of 04:37 PM ET)
Today's Range
$19.57
$20.39
50-Day Range
$17.53
$23.37
52-Week Range
$13.43
$35.09
Volume
744,408 shs
Average Volume
750,679 shs
Market Capitalization
$1.61 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.09

MaxLinear MarketRank™ Stock Analysis

Analyst Rating
Hold
2.42 Rating Score
Upside/​Downside
32.8% Upside
$26.09 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-2.19
Upright™ Environmental Score
News Sentiment
0.31mentions of MaxLinear in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.80) to $0.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.73 out of 5 stars

Computer And Technology Sector

436th out of 582 stocks

Semiconductors & Related Devices Industry

72nd out of 88 stocks

MXL stock logo

About MaxLinear Stock (NYSE:MXL)

MaxLinear, Inc. provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. The company's products are used in various electronic devices, such as radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; Wi-Fi and wireline routers for home networking; broadband modems compliant with data over cable service interface specifications, passive optical fiber standards, and digital subscriber line, as well as power management and interface products. It serves electronics distributors, module makers, original equipment manufacturers, and original design manufacturers through a direct sales force, third-party sales representatives, and a network of distributors. The company was incorporated in 2003 and is headquartered in Carlsbad, California.

MXL Stock Price History

MXL Stock News Headlines

MaxLinear (MXL) Scheduled to Post Earnings on Wednesday
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
MaxLinear (NYSE:MXL) Given New $28.00 Price Target at Benchmark
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
MaxLinear Launches Single Chip for 5G Open RAN Radio Units
MXL Sep 2024 12.500 call
MXL Dec 2024 22.500 put
See More Headlines
Receive MXL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MaxLinear and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2024
Today
4/19/2024
Next Earnings (Confirmed)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Semiconductors & related devices
Sub-Industry
Semiconductors
CUSIP
57776J10
Employees
1,328
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.09
High Stock Price Target
$30.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+28.6%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
12 Analysts

Profitability

Net Income
$-73,150,000.00
Pretax Margin
-9.20%

Debt

Sales & Book Value

Annual Sales
$693.26 million
Cash Flow
$1.79 per share
Book Value
$8.38 per share

Miscellaneous

Free Float
74,880,000
Market Cap
$1.66 billion
Optionable
Optionable
Beta
1.98
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

MXL Stock Analysis - Frequently Asked Questions

Should I buy or sell MaxLinear stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MaxLinear in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MXL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MXL, but not buy additional shares or sell existing shares.
View MXL analyst ratings
or view top-rated stocks.

What is MaxLinear's stock price target for 2024?

12 equities research analysts have issued 12-month target prices for MaxLinear's stock. Their MXL share price targets range from $18.00 to $30.00. On average, they anticipate the company's stock price to reach $26.09 in the next twelve months. This suggests a possible upside of 32.8% from the stock's current price.
View analysts price targets for MXL
or view top-rated stocks among Wall Street analysts.

How have MXL shares performed in 2024?

MaxLinear's stock was trading at $23.77 at the beginning of the year. Since then, MXL shares have decreased by 17.3% and is now trading at $19.65.
View the best growth stocks for 2024 here
.

When is MaxLinear's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our MXL earnings forecast
.

How can I listen to MaxLinear's earnings call?

MaxLinear will be holding an earnings conference call on Wednesday, April 24th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were MaxLinear's earnings last quarter?

MaxLinear, Inc. (NYSE:MXL) released its earnings results on Wednesday, January, 31st. The semiconductor company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). The semiconductor company had revenue of $125.35 million for the quarter, compared to analyst estimates of $125.06 million. MaxLinear had a negative net margin of 10.55% and a positive trailing twelve-month return on equity of 4.77%.

What guidance has MaxLinear issued on next quarter's earnings?

MaxLinear issued an update on its first quarter 2024 earnings guidance on Wednesday, January, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $85.0 million-$105.0 million, compared to the consensus revenue estimate of $121.6 million.

What is Dr. Kishore Seendripu's approval rating as MaxLinear's CEO?

56 employees have rated MaxLinear Chief Executive Officer Dr. Kishore Seendripu on Glassdoor.com. Dr. Kishore Seendripu has an approval rating of 90% among the company's employees.

What other stocks do shareholders of MaxLinear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MaxLinear investors own include Energy Transfer (ET), Lamb Weston (LW), Ford Motor (F), Advanced Micro Devices (AMD), RADCOM (RDCM), Alibaba Group (BABA), Intel (INTC), Lumentum (LITE), Micron Technology (MU) and NuStar Energy (NS).

Who are MaxLinear's major shareholders?

MaxLinear's stock is owned by many different retail and institutional investors. Top institutional shareholders include Counterpoint Mutual Funds LLC (0.02%). Insiders that own company stock include Brendan Walsh, Connie H Kwong, Curtis Ling, Daniel A Artusi, Donald E Schrock, Eugene A Hall, James Lougheed, Kishore Seendripu, Michael Bollesen, Steven G Litchfield, Steven G Litchfield, William Kelly Jones and William Torgerson.
View institutional ownership trends
.

How do I buy shares of MaxLinear?

Shares of MXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MXL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners